26/11 2024 Interim Report Q3 – January – September, 2024 Redsense Medical AB (publ.) July – September 2024 · Net sales amounted to kSEK 5,030 (5,287). · Operating loss, EBIT amounted to kSEK -3,273 (-959). · Result after tax… [read more]
24/10 2024 Redsense Medical to focus on core growth areas, discontinuing trading on OTCQX Redsense Medical AB has decided not to renew its agreement with OTC Markets Group after the current term, which ends on December 31, 2024. Redsense… [read more]
16/10 2024 Nomination committee appointed for the 2025 Annual General Meeting in Redsense Medical AB A nomination committee has been established ahead of the 2025 annual general meeting in Redsense Medical AB (publ). The nomination committee, which has been appointed… [read more]
